What is AVCN.TO's gross margin?

Avicanna (AVCN.TO) has a gross margin of 53% and a net margin of -18%.

What is AVCN.TO's P/E ratio?

Track Avicanna (AVCN.TO) P/E ratio, ROE, and valuation metrics over time.

Where can I see AVCN.TO's full financials?

See Avicanna (AVCN.TO) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Avicanna (AVCN.TO) Financials — Revenue, Earnings, Cash Flow

Also trades as: AVCNF (OTC) · $vol 0M

C$0.10 ($0.07)

+0.00 (+0.00%)

Weekly Expected Move ±13.4%

C$0 C$0 C$0 C$0 C$0

TSX · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 37 · C$12.6M mcap · 97M float · 0.163% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers

📊 Key Metrics

TTM

C$25M

Revenue

-0.2% YoY

C$-4M

Net Income

-205.3% YoY

C$-3M

Free Cash Flow

-182.6% YoY

53.1%

Gross Margin

-19.3%

Op. Margin

-18.1%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-109.4%

ROA-17.5%

ROIC-64.6%

Valuation

P/E-3.1

P/B2.7

EV/EBITDA-5.2

Leverage

Debt/Equity0.04

Current Ratio0.97

Interest Cov.-62.3x

Quality Scores

Piotroski F3/9

Altman Z-4.74

Beneish M-2.30